Literature DB >> 8062268

Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.

C L Arteaga1, S D Hurd, T C Dugger, A R Winnier, J B Robertson.   

Abstract

Epidermal growth factor (EGF) receptors are expressed in high levels by some poor prognosis breast tumors. We have examined the cytotoxic effect of the tumor growth factor alpha (TGF alpha)-delta Cys-Pseudomonas exotoxin (PE40) recombinant fusion protein on normal and tumorigenic human breast epithelial cells in vitro and in vivo. The MDA-468, MDA-231, BT-20, and MCF-7ADR estrogen receptor-negative, EGF receptor-rich breast cancer lines were exquisitely sensitive in vitro to TGF alpha-delta Cys-PE40 with a 50% inhibitory concentration of < or = 0.02 nM. The estrogen receptor-positive, low EGF receptor MCF-7, ZR75-1, and T47D cells were less sensitive to the fusion toxin with a 50% inhibitory concentration of > 0.2 nM. The nontumorigenic cell lines 184, 184A1, and 184B5 were relatively resistant to TGF alpha-delta Cys-PE40 despite exhibiting high levels of EGF receptors. Continuous i.p. administration of TGF alpha-delta Cys-PE40 via an osmotic minipump at a dose of 0.4 microgram/g/day over 7 days inhibited MDA-468, MA-231, and BT-20 but not MCF-7 tumor growth in female athymic mice. Host tissue toxicity was not observed with this dose of TGF alpha-delta Cys-PE40. Mixed MDA-468/MCF-7 tumors were established in nude mice after coinoculation of both cell types in estrogen-supplemented animals. EGF receptor immunohistochemistry and immunoblot procedures indicated that TGF alpha-PE40 eliminated the MDA-468 cells while sparing the adjacent MCF-7 cells. By immunoblot, EGF receptors were consistently more abundant in tumor tissue than in adjacent nontumor tissue from the same mastectomy specimen (n = 7). These data support the notion that EGF receptors can be selectively targeted in human breast cancer cells for the delivery of antitumor agents. Further clinical studies with TGF alpha-delta Cys-PE40 and other chimeric toxins using the same cellular target will address this possibility.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062268

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.

Authors:  T A Tetzke; M C Caton; P A Maher; Z Parandoosh
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

Review 2.  DNA repair and personalized breast cancer therapy.

Authors:  Shu-Xia Li; Ashley Sjolund; Lyndsay Harris; Joann B Sweasy
Journal:  Environ Mol Mutagen       Date:  2010 Oct-Dec       Impact factor: 3.216

Review 3.  Toward checkmate: biology and breast cancer therapy for the new millennium.

Authors:  K D Miller; G W Sledge
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

Review 4.  Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents.

Authors:  F Ciardiello
Journal:  Drugs       Date:  2000       Impact factor: 9.546

5.  Human breast tumor cells express multimodal imaging reporter genes.

Authors:  Kurt M Lin; Ching-Han Hsu; Wun-Shaing W Chang; Chiung-Tong Chen; Te-Wei Lee; Chin-Tu Chen
Journal:  Mol Imaging Biol       Date:  2008-06-17       Impact factor: 3.488

6.  Expression of antisense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon cancer cells.

Authors:  S Chakrabarty; S Rajagopal; S Huang
Journal:  Clin Exp Metastasis       Date:  1995-05       Impact factor: 5.150

7.  Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology.

Authors:  F Wang; V M Weaver; O W Petersen; C A Larabell; S Dedhar; P Briand; R Lupu; M J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  MUC1 alters oncogenic events and transcription in human breast cancer cells.

Authors:  Christine L Hattrup; Sandra J Gendler
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

9.  Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.

Authors:  Azharuddin Sajid Syed Khaja; Nishtman Dizeyi; Pradeep Kumar Kopparapu; Lola Anagnostaki; Pirkko Härkönen; Jenny Liao Persson
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

10.  Development of a human breast-cancer derived cell line stably expressing a bioluminescence resonance energy transfer (BRET)-based phosphatidyl inositol-3 phosphate (PIP3) biosensor.

Authors:  Mei-Shiue Kuo; Johanna Auriau; Cécile Pierre-Eugène; Tarik Issad
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.